NCT07481019Not yet recruiting
A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology
Source: ClinicalTrials.gov · Last updated 1 Jul 2026
Brief summary (registry, in English)
The goal of this clinical trial is to evaluate whether an electronic patient-reported outcome measure (ePROM)-guided flexible scheduling system can improve outpatient clinic resource utilisation in patients attending dermatology outpatient clinics for routine follow-up. The main questions it aims to answer are: * Does the intervention reduce the number of actualised outpatient visits over 12 months compared with standard fixed scheduling? * Does the intervention group achieve higher adherence to monthly ePROM monitoring, as measured by the proportion of completed ePROM submissions?
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- First submitted
- 15 Mar 2026
- Start date
- Sept 2026
- Primary completion date
- Jun 2029
- Lead sponsor
- National University Hospital, Singapore
- Diseases
- Atopic dermatitis (eczema), Psoriasis
- NCT number
- NCT07481019
What you commit to
- Study type: Interventional
- Planned participants: 250
- From Sept 2026 to the primary completion date, Jun 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients who require fixed or scheduled in-person visits, including those needing skin cancer surveillance, bedside procedures (e.g., liquid nitrogen therapy), surgical interventions, or routine blood tests for immunosuppressive therapy.
Who the study is looking for
- Dermatology outpatients otherwise due for a follow-up appointment within six months.
- Ability to independently navigate and complete ePROMs.
- Ability to provide informed consent (including parental consent for minors).
Age in the registry: 16 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.